Status:
COMPLETED
Nasal Intermittent Positive Pressure Ventilation During Neonatal Intubation
Lead Sponsor:
Muğla Sıtkı Koçman University
Conditions:
Respiratory Distress Syndrome
Intubation; Difficult or Failed
Eligibility:
All Genders
1-28 years
Phase:
NA
Brief Summary
The study aims to determine whether the use of nasal intermittent positive pressure ventilation (NIPPV) during neonatal endotracheal intubation increases the rate of successful intubation without phys...
Detailed Description
The present study was designed as a prospective, multicenter, randomized, controlled trial. The study was conducted at two tertiary Neonatal Intensive Care Units (Mugla Training and Research Hospital,...
Eligibility Criteria
Inclusion
- Infants of a gestational age of 22-41 weeks and undergoing oral endotracheal intubation in the neonatal intensive care within the first 28 days of life
Exclusion
- The infants who required urgent intubation,
- Infants intubated in the delivery room or the operating room,
- Infants with a heart rate of \<120/min prior to randomization,
- Infants with airway or lung anomalies,
- Infants with cyanotic congenital heart disease,
- Infants NIPPV treatment was contraindicated (congenital nasal anomaly, congenital diaphragmatic hernia, or abdominal wall defect)
Key Trial Info
Start Date :
May 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2024
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT06549283
Start Date
May 1 2023
End Date
July 15 2024
Last Update
August 12 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mugla Training and Research Hospital, Department of Neonatology
Menteşe, Muğla, Turkey (Türkiye), 48000
2
Akdeniz University School of Medicine, Department of Neonatology
Antalya, Turkey (Türkiye), 07000